Beijing Omiget Pharmaceutical Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Beijing Omiget Pharmaceutical Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include PODENIC. The owner is based in Beijing.
Biomed Ind Base, Zhongguancun s p,Daxing
Rm 206,2F,Bldg 1,No.31,Yongda rd,Daxing
Beijing 102600 , CN
Showing of trademarks Trademarks
Trademark Classifications
Beijing Omiget Pharmaceutical Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Beijing Omiget Pharmaceutical Technology Co., Ltd. have?
Beijing Omiget Pharmaceutical Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Beijing Omiget Pharmaceutical Technology Co., Ltd. file in?
Beijing Omiget Pharmaceutical Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Beijing Omiget Pharmaceutical Technology Co., Ltd.'s most well-known trademarks?
Beijing Omiget Pharmaceutical Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as PODENIC. These are among 1 currently registered trademark in the portfolio.
What is Beijing Omiget Pharmaceutical Technology Co., Ltd.'s trademark registration success rate?
Beijing Omiget Pharmaceutical Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.